Suppr超能文献

相似文献

1
Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS.
Antioxid Redox Signal. 2009 Jul;11(7):1603-14. doi: 10.1089/ars.2009.2536.
2
SOD1 aggregation and ALS: role of metallation states and disulfide status.
Curr Top Med Chem. 2012;12(22):2560-72. doi: 10.2174/1568026611212220010.
4
Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.
Exp Biol Med (Maywood). 2009 Oct;234(10):1140-54. doi: 10.3181/0903-MR-104. Epub 2009 Jul 13.
5
Copper and zinc metallation status of copper-zinc superoxide dismutase from amyotrophic lateral sclerosis transgenic mice.
J Biol Chem. 2011 Jan 28;286(4):2795-806. doi: 10.1074/jbc.M110.186999. Epub 2010 Nov 10.
8
Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.
Acta Neuropathol. 2010 Mar;119(3):335-44. doi: 10.1007/s00401-010-0646-5. Epub 2010 Jan 29.
10
Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
J Neurochem. 2008 Feb;104(4):993-1005. doi: 10.1111/j.1471-4159.2007.05053.x.

引用本文的文献

2
Structural insights into the role of reduced cysteine residues in SOD1 amyloid filament formation.
Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2408582122. doi: 10.1073/pnas.2408582122. Epub 2025 Jan 28.
3
Amyloid fibril structures and ferroptosis activation induced by ALS-causing SOD1 mutations.
Sci Adv. 2024 Nov;10(44):eado8499. doi: 10.1126/sciadv.ado8499. Epub 2024 Oct 30.
4
Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model.
Mol Ther Methods Clin Dev. 2024 Aug 6;32(3):101312. doi: 10.1016/j.omtm.2024.101312. eCollection 2024 Sep 12.
6
Oxidized SOD1 accelerates cellular senescence in neural stem cells.
Stem Cell Res Ther. 2024 Feb 27;15(1):55. doi: 10.1186/s13287-024-03669-5.
8
Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosis.
Cell Mol Life Sci. 2023 Sep 26;80(10):304. doi: 10.1007/s00018-023-04956-9.
10
The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases.
CNS Neurosci Ther. 2023 Jan;29(1):37-59. doi: 10.1111/cns.13985. Epub 2022 Oct 2.

本文引用的文献

1
Initiation and elongation in fibrillation of ALS-linked superoxide dismutase.
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18663-8. doi: 10.1073/pnas.0807058105. Epub 2008 Nov 20.
3
Structures of the G85R variant of SOD1 in familial amyotrophic lateral sclerosis.
J Biol Chem. 2008 Jun 6;283(23):16169-77. doi: 10.1074/jbc.M801522200. Epub 2008 Mar 31.
4
Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications.
Antioxid Redox Signal. 2008 Mar;10(3):405-43. doi: 10.1089/ars.2007.1760.
6
SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization.
PLoS One. 2008 Feb 27;3(2):e1677. doi: 10.1371/journal.pone.0001677.
8
Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models.
Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14157-62. doi: 10.1073/pnas.0700477104. Epub 2007 Aug 21.
9
Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis.
Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12524-9. doi: 10.1073/pnas.0705044104. Epub 2007 Jul 16.
10
Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS.
Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11263-7. doi: 10.1073/pnas.0704307104. Epub 2007 Jun 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验